Charles River Laboratories International Inc

자세한 내용은 Charles River Laboratories International Inc 회사

Charles River Laboratories International, Inc. is a drug development company. It provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and academic institutions around the globe accelerate their research and drug development efforts. Its Research Models and Services segment includes three businesses that provide foundational tools that enable its clients to discover new molecules: Research Models, Research Model Services, and Cell Solutions. Its Discovery and Safety Assessment segment provides regulated and non-regulated DSA services to support the research, development, and regulatory-required safety testing of potential new drugs, including therapeutic discovery and optimization plus in vitro and in vivo studies, laboratory support services, and strategic non-clinical consulting and program management to support product development. Its Manufacturing Solutions segment includes Microbial Solutions and Biologics Solutions.

회사 정보

종목 코드 CRL

회사 이름Charles River Laboratories International Inc

상장일Jun 23, 2000

설립일1994

CEOMr James C. Foster

직원 수18600

유형Ordinary Share

회계 연도 종료Jun 23

주소251 Ballardvale St

도시WILMINGTON

증권 거래소NYSE Consolidated

국가United States of America

우편 번호01887

전화17812226000

웹사이트https://www.criver.com/

종목 코드 CRL

상장일Jun 23, 2000

설립일1994

회사 임원

이름

이름/직위

직위

주식 보유

변동

Mr James C. Foster

Chairman of the Board, President, Chief Executive Officer

267.96K

+6.88%

Ms. Birgit Girshick

Chief Operating Officer, Corporate Executive Vice President

57.72K

+24.38%

Ms. Victoria L. (Vicky) Creamer

Corporate Executive Vice President, Chief People Officer

17.89K

+48.67%

Mr. Joseph W. LaPlume

Corporate Executive Vice President - Corporate Development and Strategy

13.68K

-2.74%

Ms. Shannon M. Parisotto

Corporate Executive Vice President - Discovery and Safety Assessment Management

12.88K

+69.56%

Ms. Virginia M. (Gina) Wilson, CPA

Independent Director

4.91K

+23.86%

Dr. Nancy C. Andrews, M.D., Ph.D.

Independent Director

3.96K

+31.35%

Ms. Reshema Kemps-Polanco

Independent Director

2.59K

+155.42%

Dr. Craig B. Thompson, M.D.

Independent Director

2.41K

+64.49%

Mr. Abraham N. (Abe) Ceesay

Independent Director

946.00

--

이름

이름/직위

직위

주식 보유

변동

Mr James C. Foster

Chairman of the Board, President, Chief Executive Officer

267.96K

+6.88%

Ms. Birgit Girshick

Chief Operating Officer, Corporate Executive Vice President

57.72K

+24.38%

Ms. Victoria L. (Vicky) Creamer

Corporate Executive Vice President, Chief People Officer

17.89K

+48.67%

Mr. Joseph W. LaPlume

Corporate Executive Vice President - Corporate Development and Strategy

13.68K

-2.74%

Ms. Shannon M. Parisotto

Corporate Executive Vice President - Discovery and Safety Assessment Management

12.88K

+69.56%

Ms. Virginia M. (Gina) Wilson, CPA

Independent Director

4.91K

+23.86%

수익 분석

통화: USD마지막 업데이트: Sun, Jul 6

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

FY2020

FY2019

FY2018

FY2017

FY2016

FY2015

사업별USD

이름

수익

비율

DSA

592.61M

60.21%

RMS

213.07M

21.65%

Manufacturing

178.49M

18.14%

지역별USD

이름

수익

비율

United States

536.96M

54.56%

Europe

263.25M

26.75%

Canada

125.35M

12.74%

Asia Pacific (Region)

41.94M

4.26%

Other

16.67M

1.69%

사업별

지역별

사업별USD

이름

수익

비율

DSA

592.61M

60.21%

RMS

213.07M

21.65%

Manufacturing

178.49M

18.14%

주식 보유 통계

마지막 업데이트: Sat, May 17

주주

주주 유형

주주

비율

The Vanguard Group, Inc.

12.41%

Wellington Management Company, LLP

8.72%

BlackRock Institutional Trust Company, N.A.

5.92%

UBS Financial Services, Inc.

4.86%

Allspring Global Investments, LLC

4.66%

Other

63.42%

주주

비율

The Vanguard Group, Inc.

12.41%

Wellington Management Company, LLP

8.72%

BlackRock Institutional Trust Company, N.A.

5.92%

UBS Financial Services, Inc.

4.86%

Allspring Global Investments, LLC

4.66%

Other

63.42%

주주 유형

주주

비율

Investment Advisor

51.51%

Investment Advisor/Hedge Fund

40.20%

Hedge Fund

7.75%

Research Firm

7.62%

Pension Fund

1.84%

Bank and Trust

1.48%

Sovereign Wealth Fund

1.10%

Individual Investor

1.05%

Insurance Company

0.08%

기관 주식 보유

마지막 업데이트: Tue, Jul 1

보고 기간

기관 수

보유 주식

비율

변동

2025Q2

1392

55.35M

112.69%

-5.40M

2025Q1

1435

55.38M

112.72%

-5.93M

2024Q4

1423

54.85M

107.26%

-4.35M

2024Q3

1392

53.78M

105.14%

-5.12M

2024Q2

1399

54.00M

104.84%

-4.00M

2024Q1

1393

53.76M

104.37%

-4.04M

2023Q4

1424

53.56M

104.42%

-4.24M

2023Q3

1446

53.56M

104.42%

-3.98M

2023Q2

1427

52.88M

103.32%

-3.95M

2023Q1

1431

52.72M

103.01%

-2.79M

주주 활동

이름

보유 주식

비율

변동

Chg %

날짜

The Vanguard Group, Inc.

6.09M

12.41%

-39.84K

-0.65%

Mar 31, 2025

Wellington Management Company, LLP

4.29M

8.72%

+208.59K

+5.12%

Mar 31, 2025

BlackRock Institutional Trust Company, N.A.

2.91M

5.92%

-42.75K

-1.45%

Mar 31, 2025

UBS Financial Services, Inc.

2.39M

4.86%

+2.09M

+702.65%

Mar 31, 2025

Allspring Global Investments, LLC

1.77M

3.61%

-33.40K

-1.85%

Mar 31, 2025

Kayne Anderson Rudnick Investment Management, LLC

1.95M

3.97%

+144.73K

+8.02%

Mar 31, 2025

State Street Global Advisors (US)

1.90M

3.87%

-278.81K

-12.78%

Mar 31, 2025

Geode Capital Management, L.L.C.

1.26M

2.57%

+30.45K

+2.47%

Mar 31, 2025

Impactive Capital LP

1.21M

2.47%

+9.20K

+0.77%

Mar 31, 2025

Ariel Investments, LLC

1.10M

2.24%

+33.45K

+3.13%

Mar 31, 2025

166.910USD

Charles River Laboratories International Inc

166.910

개요

회사

금융